Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001179110-22-003402

Options or other derivatives

  • Corporate Controller acquired 8,477 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lorenzo Pierre Corporate Controller 2022-06-21 Grant or award · Stock Option (Right to Buy) +8,477 8,477 D
Loading xslF345X03/edgar.xml…